bpc-157 synthetic gastric pentadecapeptide Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157: The Gastric Peptide Behind

BPC-157 was shown in rat models to combat heart failure via the NO system, echoing emerging gene therapy modalities in ED treatment

This enzyme is involved in metabolic regulation and may influence how cells manage energy

As the name implies, hepcidins are predominantly expressed in the liver, but they are also found in much smaller amounts in the heart, brain, lung [154], and body fluids like urine [156]

However, these datasets are largely composed of patients from European ancestry, highlighting the immense value of including more diverse populations to achieve a global understanding of T1D and ensure that current models and therapies are applicable and effective for all patients